Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. HMN
HMN logo

HMN Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Horace Mann Educators Corp (HMN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
45.330
1 Day change
0.13%
52 Week Range
48.330
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Horace Mann Educators Corp (HMN) is not a strong buy at the moment for a beginner investor with a long-term focus. The stock lacks significant positive catalysts, has neutral trading trends, and its financial performance shows declining net income and EPS despite revenue growth. Additionally, no proprietary trading signals or recent news events indicate a compelling entry point.

Technical Analysis

The MACD is positive but contracting, indicating weakening momentum. RSI is neutral at 64.864, and moving averages are converging, suggesting no clear trend. The stock is trading near its pivot level of 44.026, with resistance at 45.141 and support at 42.911.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
2
Buy
9

Positive Catalysts

  • Revenue increased by 8.46% YoY in 2025/Q4.

Neutral/Negative Catalysts

  • Net income dropped by -5.24% YoY, and EPS declined by -5.43% YoY. No recent news or significant trading trends from hedge funds, insiders, or Congress. The stock has a 60% chance of declining over the next month based on candlestick pattern analysis.

Financial Performance

In 2025/Q4, revenue increased to $440.9M (up 8.46% YoY), but net income dropped to $36.2M (down -5.24% YoY), and EPS fell to 0.87 (down -5.43% YoY).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst ratings or price target changes available.

Wall Street analysts forecast HMN stock price to rise
1 Analyst Rating
Wall Street analysts forecast HMN stock price to rise
0 Buy
1 Hold
0 Sell
Hold
Current: 45.270
sliders
Low
48
Averages
48
High
48
Current: 45.270
sliders
Low
48
Averages
48
High
48
BMO Capital
Michael Zaremski
Outperform
initiated
$48
AI Analysis
2025-07-28
Reason
BMO Capital
Michael Zaremski
Price Target
$48
AI Analysis
2025-07-28
initiated
Outperform
Reason
BMO Capital analyst Michael Zaremski initiated coverage of Horace Mann with an Outperform rating and $48 price target. The company's captive-focused distribution differs from the majority of peer insurers who rely on 3rd party independent sales agents, the analyst tells investors in a research note. BMO adds that Horace Mann's strategy of selling mainly to schoolteachers via its captive salesforce is one that can bear meaningful fruit, so long as it executes on its current revamped sales strategy.
Piper Sandler
Neutral
maintain
$44 -> $45
2025-07-03
Reason
Piper Sandler
Price Target
$44 -> $45
2025-07-03
maintain
Neutral
Reason
Piper Sandler raised the firm's price target on Horace Mann to $45 from $44 and keeps a Neutral rating on the shares. The firm is reducing its EPS estimates in the space driven by continued fee and spread headwinds. This was confirmed by a rather challenging pre-announcement of variable investment income from MetLife (MET) in late June suggesting this swing factor for a large chunk of lifecoland got sequentially worse, which also - in Piper's opinion - pushes out the normalization factor towards 2026.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for HMN
Unlock Now

People Also Watch